Is India Quietly Becoming a Favourable Hub for Clinical Trials?

Authors

  • Deepali Desai Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India
  • Nikunja Kumar Das Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India
  • Sahjid Mukhida Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India
  • Radhika Paranjpe Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India

DOI:

https://doi.org/10.55489/njcm.140920233201

Keywords:

Clinical trial, India, Hub, Ethics

Abstract

In recent years, India has become a go-to destination hub for clinical trials. The manpower, labour, patient recruitment, and medical infrastructure are cost-effective. India has a growing number of world-class research facilities and hospitals well equipped with advanced medical technology, which is essential for conducting high-quality clinical trials.

References

De A. Robust regulations, skilled professionals, Diverse pa-tient pool: Why India is becoming hub for drug trials. Available from https://news.abplive.com/india-at-2047/why-india-is-becoming-one-of. Last assessed on 19.05.2023.

Why India a favourite hub for clinical trials. Available from https://crbtech.in/india-favourite-hub-clinical-trials. Last assessed on 19.05.2023.

India an attractive hub for clinical research. Available from https://www.veedacr.com/india-an-attractive-hub-for-clinical-research. Last assessed on 19.05.2023.

Das NK, Patil R, Prasanna S, Das P, Mukhida S. Drones for Med-ical Supply During Disaster: A Game Changer in "Health for All" Policy. Health Services Insights. 2023;16. Doi: https://doi.org/10.1177/11786329231160013 PMid:36896146 PMCid:PMC9989367

Aksa. Can India serve as a hub for clinical trials? Despite the optimism of the drug industry, it should not recreate prior errors. Available from ttps://www.inventiva.co.in/trends/can-india-serve-as-a-hub-for-clinical-trials. Last assessed on 19.05.2023.

Thacker T. India emerging as a top destination for clinical tri-als, says report. Available from https://economictimes.india times.com/industry/healthcare//biotech/… Last assessed on 17.7.2023.

Hegde R. Why India is most preferred Clinical trial destina-tion. Available from www. biospectrumasia.com/article/pdf/ 22674. Last assessed on 17.7.2023.

Downloads

Published

2023-09-01

How to Cite

1.
Desai D, Das NK, Mukhida S, Paranjpe R. Is India Quietly Becoming a Favourable Hub for Clinical Trials?. Natl J Community Med [Internet]. 2023 Sep. 1 [cited 2024 Jul. 21];14(09):626-7. Available from: https://njcmindia.com/index.php/file/article/view/3201

Issue

Section

Letter to Editor